Related Experiment Videos
Bisphosphonates in breast cancer patients with skeletal metastases
1Breast Evaluation Center, Dana-Farber Cancer Institute, Boston, Massachusetts.
Hematology/Oncology Clinics of North America
|February 1, 1994
Abstract:
The utility of bisphosphonates is well established in the treatment of acute hypercalcemia of malignancy. Bisphosphonates may also decrease the complications and morbidity of skeletal metastases. This article emphasizes the use of bisphosphonates in breast cancer patients with skeletal metastases.